Staphylococcus epidermidis (SE) is the leading pathogen of prosthetic valve endocarditis.
SUMMARY
Staphylococcus epidermidis (SE) is the leading pathogen of prosthetic valve endocarditis.
At the same time it is a very rare cause of native valve endocarditis and it follows a clinical course and outcome similar to Streptococcal viridans endocarditis.
We report here the case of a 41-year-old man with a community acquired SE endocarditis of a native aortic valve. Despite early surgical intervention, the case followed an acute and fatal course.
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Bacterial endocarditis Staphylococcus epidermidis Native valve endocarditis TAPHYLOCOCCUS epidermidis (SE), or coagulase negative staphylococcus, is being recognized increasingly as a pathogen. These organisms are the most frequent cause of positive blood cultures in the hospital1) and they are common causes of infections around prosthetic devices and in immunosuppressed patients. Staphylococcus epidermidis is now recognized as the most common cause of prosthetic valve endocarditis.
Conversely, it is rarely a cause of native valve endocarditis.
The subacute course of these two forms of endocarditis are differentiated by the high mortality rate of prosthetic valve endocarditis, the fact that the native valve endocarditis is a community acquired infection that resembles the subacute bacterial endocarditis caused by Streptococcus viridans in its susceptibility to antibiotics, and the prognosis. We recently treated a patient with a community acquired endocarditis of a native aortic valve caused by SE. The clinical course was fulminant with the development of perivalvular and myocardial absces-ses and congestive heart failure. serum bactericidal titer of 1/16. Recent reports showed that routine susceptibility testing of SE may falsely label some strains of this organism as susceptible to commonly used antibiotics.35) When no rapid clinical improvement occur, the immediate change of the prescribed antibiotic regimen or addition of another antibiotic is the recommended approach. This is particularly important because in vitro studies cannot form an objective basis for therapy selection in SE endocarditis.
Host factors like age, underlying diseases and severity of the endocarditis at the time of diagnosis will influence the outcome.36), 37) Finally, a role of emergency surgery in infective endocarditis cannot be overemphasized in cases in which the chemotherapy fails or potential lethal complications emerge (e.g. severe heart failure, VSD).23)
